Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,817 | -15,800 | -9,052 | -3,845 | -25,954 |
| Depreciation Amortization | 1,852 | 1,077 | 731 | 671 | 2,612 |
| Accounts receivable | 179 | -670 | -508 | -361 | -1,454 |
| Accounts payable and accrued liabilities | -967 | -500 | -915 | -817 | -80 |
| Other Working Capital | -2,613 | -2,218 | -1,771 | -1,923 | -400 |
| Other Operating Activity | -3,334 | 2,972 | 1,950 | 2,165 | 3,699 |
| Operating Cash Flow | $-19,700 | $-15,139 | $-9,565 | $-4,110 | $-21,577 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,190 | 2,417 | 1,024 | -4,231 | -3,779 |
| PPE Investments | -616 | -294 | -156 | -131 | -759 |
| Other Investing Activity | 48 | -1,259 | -2,020 | 0 | 0 |
| Investing Cash Flow | $9,622 | $864 | $-1,152 | $-4,362 | $-4,538 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 123 | 5,623 | 86 | 3 | 8,449 |
| Other Financing Activity | 4,533 | -761 | -604 | -370 | 9,703 |
| Financing Cash Flow | $4,656 | $4,862 | $-518 | $-367 | $18,152 |
| Exchange Rate Effect | -49 | -42 | -53 | -18 | -245 |
| Beginning Cash Position | 20,772 | 20,772 | 20,772 | 20,772 | 28,980 |
| End Cash Position | 15,301 | 11,317 | 9,484 | 11,915 | 20,772 |
| Net Cash Flow | $-5,471 | $-9,455 | $-11,288 | $-8,857 | $-8,208 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,700 | -15,139 | -9,565 | -4,110 | -21,577 |
| Capital Expenditure | -626 | -304 | -166 | -141 | -785 |
| Free Cash Flow | -20,326 | -15,443 | -9,731 | -4,251 | -22,362 |